Patent · US Active

Salt of ABT-263 and solid-state forms thereof

US8362013B2 · kind B2 · utility

1Cited by

13References

10Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Thomas B. Borchardt · Kenosha, US
Paul J. Brackemeyer · Mount Prospect, US
Nathaniel Catron · Vernon Hills, US
Rodger F. Henry · Park City, US
Xiaochun Lou · Long Grove, US
Matthew M. Ravn · Round Lake Beach, US
Geoff G. Zhang · Vernon Hills, US
Deliang Zhou · Vernon Hills, US

Key dates

Filing date	Apr 29, 2010
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Nov 17, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

ABT-263 bis-HCl and crystalline polymorphs thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.